Senzime AB (SEZI) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

The company has declared Positive results for the last 8 consecutive quarters

OPERATING CASH FLOW(Y) Highest at SEK -103.29 MM
NET PROFIT(HY) Higher at SEK -69.01 MM
DEBTORS TURNOVER RATIO(HY) Highest at 4.81%

Risky -

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

SEK 836 Million (Small Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.30

Return on Equity

-34.63%

Price to Book

2.40

Revenue and Profits:

Net Sales:

26 Million

(Quarterly Results - Jun 2025)

Net Profit:

-34 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-24.49%

6 Months

-6.13%

1 Year

-15.94%

2 Years

-21.67%

3 Years

-58.33%

4 Years

-76.11%

5 Years

-77.97%

Senzime AB for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

60.10%

EBIT Growth (5y)

-193.00%

EBIT to Interest (avg)

-60.35

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.19

Sales to Capital Employed (avg)

0.16

Tax Ratio

3.18%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.50

EV to EBIT

-6.61

EV to EBITDA

-8.11

EV to Capital Employed

3.31

EV to Sales

9.89

PEG Ratio

Dividend Yield

ROCE (Latest)

-50.03%

ROE (Latest)

-34.03%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 72.48% vs 75.29% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -2.69% vs 2.91% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "25.70",
          "val2": "14.90",
          "chgp": "72.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-23.60",
          "val2": "-29.90",
          "chgp": "21.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8.90",
          "val2": "0.20",
          "chgp": "4,350.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-34.30",
          "val2": "-33.40",
          "chgp": "-2.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,145.90%",
          "val2": "-2,314.40%",
          "chgp": "116.85%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 63.41% vs 155.71% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 11.48% vs -1.06% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "58.50",
          "val2": "35.80",
          "chgp": "63.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-114.10",
          "val2": "-116.30",
          "chgp": "1.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.00",
          "val2": "0.80",
          "chgp": "25.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-118.70",
          "val2": "-134.10",
          "chgp": "11.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,267.10%",
          "val2": "-3,742.60%",
          "chgp": "147.55%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

25.70

14.90

72.48%

Operating Profit (PBDIT) excl Other Income

-23.60

-29.90

21.07%

Interest

8.90

0.20

4,350.00%

Exceptional Items

0.00

Consolidate Net Profit

-34.30

-33.40

-2.69%

Operating Profit Margin (Excl OI)

-1,145.90%

-2,314.40%

116.85%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 72.48% vs 75.29% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -2.69% vs 2.91% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

58.50

35.80

63.41%

Operating Profit (PBDIT) excl Other Income

-114.10

-116.30

1.89%

Interest

1.00

0.80

25.00%

Exceptional Items

0.00

Consolidate Net Profit

-118.70

-134.10

11.48%

Operating Profit Margin (Excl OI)

-2,267.10%

-3,742.60%

147.55%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 63.41% vs 155.71% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 11.48% vs -1.06% in Dec 2023

All Annual Results

Company CV

About Senzime AB

Senzime AB

Pharmaceuticals & Biotechnology

Senzime publ AB is a Sweden-based company engaged in the development, manufacture and marketing of biosensors for measuring metabolites in biological fluids, such as human blood and cell culture substrates for the pharmaceutical and healthcare segments. The Company focuses on the following application areas: medical diagnostic instruments, pharmaceutical industry, chemical processing, and food and beverage processing. As of December 31, 2011, the Company marketed three products, namely SENZ-100G, for continuous analysis of glucose in the fermentation solutions; SENZ-100L, for continuous analysis of lactate in fermentation solutions, and SENZ-200G, for continuous analysis of glucose in blood during intensive care.

Company Coordinates

Company Details

Ulls Vag 29 , UPPSALA None : 756 51

Tel: 46 18 515640

https://www.senzime.com/

Registrar Details